C. Robalo Cordeiro Jr (Coimbra, Portugal), V. Poletti (Forli, Italy)
Diffuse parenchymal lung inflammation response in patients with inflammatory bowel disease
V. Dinic-Radovic, A. Nagorni, M. Radovic, B. Radovanovic (Nis, Serbia And Montenegro)
|  |
Angiogenesis and coagulation in the development of pulmonary hypertension in idiopathic interstitial pneumonias (IIP)
E. N. Popova, E. A. Kogan (Moscow, Russian Federation)
| |
Quality of life in patients of interstitial lung diseases from India
J. Bhargava, M. Sircar, A. Jaiswal, K. Gupta, P. P. Sharma, K. Vani (New Delhi, Faridabad, India)
| |
Expression of p53, p21 and bcl 2 in patients with cryptogenic organizing pneumonia
M. Plataki, A. V. Koutsopoulos, H. Tzortzaki, C. Dambaki, K. Darivianaki, E. Stathopoulos, B. Demosthenes, N. M. Siafakas (Heraklion, Alexandroupolis, Greece)
| |
Increased BALF eosinophils and underlying interstitial lung disease
D. S. Papakosta, K. I. Manika, G. O. Kyriazis, N. D. Manolakoglou, T. N. Kontakiotis, D. E. Bouros, D. G. Gioulekas (Thessaloniki, Greece)
| |
Hand-Schuller-Christian syndrome: diagnosis and treatment
O. P. Baranova, E. M. Dembo-Smeathon, I. V. Dvorakovskaya, I. A. Moshkalova, N. G. Yakovleva (St. Petersburg, Russian Federation)
| |
Clinical and pathological findings of patients with interstitial lung diseases associated with antisynthetase other than Jo-1 antibodies
H. Hara, T. Mochizuki, F. Kotajima, T. Sato, M. Hirakata (Tokyo, Japan)
| |
Pulmonary alveolar proteinosis (PAP) - clinical features and response to treatment by bronchofiberoscopic lobar lavage
M. Sobiecka, R. Langfort, I. Bestry, P. Radwan-Roehrenschef, J. Kus (Warsaw, Poland)
| |
Autopsy-proven causes of diffuse pulmonary infiltrate in patients infected with HIV
E. R. Parra, A. N. Santana, S. C. Ribeiro, F. S. Nunes, V. L. Capelozzi (Sao Paulo, Brazil)
| |
Angiotensin-converting enzyme insertion/deletion gene polymorphism and interstitial pulmonary fibrosis in Iranian population
F. Mohammadi, A. Dorodinia, Z. Mohammadtaheri, A. Mirafsharieh, M. Shaikholeslam, V. Bakayof, M. Bahadori, M. Masjedi (Tehran, Islamic Republic Of Iran)
| |
Correlations of collagen matrix between nonspecific interstitial pneumonia and collagen disease - preliminary study
E. R. Parra, C. H. Felício, V. L. Capelozzi (Sao Paulo, Brazil)
| |
Diagnostic aspects of exogenous toxic alveolitis (ETA), due to polymetallic aerosols
G. P. Orlova, I. V. Dvorakovskaya, N. G. Yakovleva (St. Petersburg, Russian Federation)
| |
Interstitial lung diseases: ten years‘ experience
M. A. Dimadi, R. Triggidou, J. Tsiaras, K. Mara, E. Stefanaki, A. Xypolytos, F. Vlastos, A. G. Nicholson, D. Bouros (Athens, Greece; London, United Kingdom)
| |
Fas Ligand (FasL) expressed on alveolar lymphocytes (AL) plays role in progression of interstitial lung diseases (ILD) but not in local induction of immune cells apoptosis
G. Pinis, P. Kopinski, J. Soja, M. Wos, K. Sladek (Krakow, Bydgoszcz, Poland)
| |
Increased alveolar concentrations of exhaled nitric oxide (NO) are associated with lung affection in systemic sclerosis (SSc)
K. P. Tiev, J. Cabane, A. T. Dinh-Xuan (Paris, France)
| |
Goodpasture syndrome with alveolar hemorrhage: a retrospective analysis of 28 cases
R. Lazor, L. Bigay-Gamé, J. Cadranel, V. Cottin, P. Delaval, J. Cordier, T. G. (Bern, Switzerland; Toulouse, Paris, Lyon, Rennes, France)
| |
Phenotypic analysis of BAL lympocytes and respiratory function in chronic inflammatory lung diseases
N. Stanflin, E. Rosi, S. Orsi, K. Ferrari, M. G. Giudizi, R. Biagiotti, A. Corrado, S. Nutini (Florence, Italy)
| |
The oxidant-antioxidant balance in systemic sclerosis cases with interstitial lung involvement
B. Musellim, H. Ikitimur, H. Uzun, G. Ongen (Istanbul, Turkey)
| |